Advanced Energy Storage
Advanced Energy Storage market is segmented by players, region (country), by Type and by Applicat ... Read More
1 Non-opioid Pain Patches Market Overview 1.1 Product Overview and Scope of Non-opioid Pain Patches 1.2 Non-opioid Pain Patches Segment by Type 1.2.1 Global Non-opioid Pain Patches Sales Growth Rate Comparison by Type (2022-2028) 1.2.2 Lidocaine Patch 1.2.3 Diclofenac Patch 1.2.4 Methyl Salicylate Patch 1.2.5 Capsaicin Patch 1.2.6 Ketoprofen Patch 1.2.7 Others 1.3 Non-opioid Pain Patches Segment by Application 1.3.1 Global Non-opioid Pain Patches Sales Comparison by Application: (2022-2028) 1.3.2 Hospital Pharmacies 1.3.3 Independent Pharmacies & Drug Stores 1.3.4 Online Pharmacies 1.4 Global Non-opioid Pain Patches Market Size Estimates and Forecasts 1.4.1 Global Non-opioid Pain Patches Revenue 2017-2028 1.4.2 Global Non-opioid Pain Patches Sales 2017-2028 1.4.3 Non-opioid Pain Patches Market Size by Region: 2017 Versus 2021 Versus 2028 2 Non-opioid Pain Patches Market Competition by Manufacturers 2.1 Global Non-opioid Pain Patches Sales Market Share by Manufacturers (2017-2022) 2.2 Global Non-opioid Pain Patches Revenue Market Share by Manufacturers (2017-2022) 2.3 Global Non-opioid Pain Patches Average Price by Manufacturers (2017-2022) 2.4 Manufacturers Non-opioid Pain Patches Manufacturing Sites, Area Served, Product Type 2.5 Non-opioid Pain Patches Market Competitive Situation and Trends 2.5.1 Non-opioid Pain Patches Market Concentration Rate 2.5.2 The Global Top 5 and Top 10 Largest Non-opioid Pain Patches Players Market Share by Revenue 2.5.3 Global Non-opioid Pain Patches Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 3 Non-opioid Pain Patches Retrospective Market Scenario by Region 3.1 Global Non-opioid Pain Patches Retrospective Market Scenario in Sales by Region: 2017-2022 3.2 Global Non-opioid Pain Patches Retrospective Market Scenario in Revenue by Region: 2017-2022 3.3 North America Non-opioid Pain Patches Market Facts & Figures by Country 3.3.1 North America Non-opioid Pain Patches Sales by Country 3.3.2 North America Non-opioid Pain Patches Revenue by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe Non-opioid Pain Patches Market Facts & Figures by Country 3.4.1 Europe Non-opioid Pain Patches Sales by Country 3.4.2 Europe Non-opioid Pain Patches Revenue by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Non-opioid Pain Patches Market Facts & Figures by Region 3.5.1 Asia Pacific Non-opioid Pain Patches Sales by Region 3.5.2 Asia Pacific Non-opioid Pain Patches Revenue by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America Non-opioid Pain Patches Market Facts & Figures by Country 3.6.1 Latin America Non-opioid Pain Patches Sales by Country 3.6.2 Latin America Non-opioid Pain Patches Revenue by Country 3.6.3 Mexico 3.6.4 Brazil 3.6.5 Argentina 3.7 Middle East and Africa Non-opioid Pain Patches Market Facts & Figures by Country 3.7.1 Middle East and Africa Non-opioid Pain Patches Sales by Country 3.7.2 Middle East and Africa Non-opioid Pain Patches Revenue by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 U.A.E 4 Global Non-opioid Pain Patches Historic Market Analysis by Type 4.1 Global Non-opioid Pain Patches Sales Market Share by Type (2017-2022) 4.2 Global Non-opioid Pain Patches Revenue Market Share by Type (2017-2022) 4.3 Global Non-opioid Pain Patches Price by Type (2017-2022) 5 Global Non-opioid Pain Patches Historic Market Analysis by Application 5.1 Global Non-opioid Pain Patches Sales Market Share by Application (2017-2022) 5.2 Global Non-opioid Pain Patches Revenue Market Share by Application (2017-2022) 5.3 Global Non-opioid Pain Patches Price by Application (2017-2022) 6 Key Companies Profiled 6.1 Pfizer 6.1.1 Pfizer Corporation Information 6.1.2 Pfizer Description and Business Overview 6.1.3 Pfizer Non-opioid Pain Patches Sales, Revenue and Gross Margin (2017-2022) 6.1.4 Pfizer Non-opioid Pain Patches Product Portfolio 6.1.5 Pfizer Recent Developments/Updates 6.2 GlaxoSmithKline 6.2.1 GlaxoSmithKline Corporation Information 6.2.2 GlaxoSmithKline Description and Business Overview 6.2.3 GlaxoSmithKline Non-opioid Pain Patches Sales, Revenue and Gross Margin (2017-2022) 6.2.4 GlaxoSmithKline Non-opioid Pain Patches Product Portfolio 6.2.5 GlaxoSmithKline Recent Developments/Updates 6.3 Johnson & Johnson 6.3.1 Johnson & Johnson Corporation Information 6.3.2 Johnson & Johnson Description and Business Overview 6.3.3 Johnson & Johnson Non-opioid Pain Patches Sales, Revenue and Gross Margin (2017-2022) 6.3.4 Johnson & Johnson Non-opioid Pain Patches Product Portfolio 6.3.5 Johnson & Johnson Recent Developments/Updates 6.4 Novartis AG 6.4.1 Novartis AG Corporation Information 6.4.2 Novartis AG Description and Business Overview 6.4.3 Novartis AG Non-opioid Pain Patches Sales, Revenue and Gross Margin (2017-2022) 6.4.4 Novartis AG Non-opioid Pain Patches Product Portfolio 6.4.5 Novartis AG Recent Developments/Updates 6.5 Mylan N.V. 6.5.1 Mylan N.V. Corporation Information 6.5.2 Mylan N.V. Description and Business Overview 6.5.3 Mylan N.V. Non-opioid Pain Patches Sales, Revenue and Gross Margin (2017-2022) 6.5.4 Mylan N.V. Non-opioid Pain Patches Product Portfolio 6.5.5 Mylan N.V. Recent Developments/Updates 6.6 Teva Pharmaceutical Industries 6.6.1 Teva Pharmaceutical Industries Corporation Information 6.6.2 Teva Pharmaceutical Industries Description and Business Overview 6.6.3 Teva Pharmaceutical Industries Non-opioid Pain Patches Sales, Revenue and Gross Margin (2017-2022) 6.6.4 Teva Pharmaceutical Industries Non-opioid Pain Patches Product Portfolio 6.6.5 Teva Pharmaceutical Industries Recent Developments/Updates 6.7 Hisamitsu Pharmaceutical 6.6.1 Hisamitsu Pharmaceutical Corporation Information 6.6.2 Hisamitsu Pharmaceutical Description and Business Overview 6.6.3 Hisamitsu Pharmaceutical Non-opioid Pain Patches Sales, Revenue and Gross Margin (2017-2022) 6.4.4 Hisamitsu Pharmaceutical Non-opioid Pain Patches Product Portfolio 6.7.5 Hisamitsu Pharmaceutical Recent Developments/Updates 6.8 TEH SENG Pharmaceutical 6.8.1 TEH SENG Pharmaceutical Corporation Information 6.8.2 TEH SENG Pharmaceutical Description and Business Overview 6.8.3 TEH SENG Pharmaceutical Non-opioid Pain Patches Sales, Revenue and Gross Margin (2017-2022) 6.8.4 TEH SENG Pharmaceutical Non-opioid Pain Patches Product Portfolio 6.8.5 TEH SENG Pharmaceutical Recent Developments/Updates 6.9 Teikoku Seiyaku 6.9.1 Teikoku Seiyaku Corporation Information 6.9.2 Teikoku Seiyaku Description and Business Overview 6.9.3 Teikoku Seiyaku Non-opioid Pain Patches Sales, Revenue and Gross Margin (2017-2022) 6.9.4 Teikoku Seiyaku Non-opioid Pain Patches Product Portfolio 6.9.5 Teikoku Seiyaku Recent Developments/Updates 6.10 IBSA Institut Biochimque SA 6.10.1 IBSA Institut Biochimque SA Corporation Information 6.10.2 IBSA Institut Biochimque SA Description and Business Overview 6.10.3 IBSA Institut Biochimque SA Non-opioid Pain Patches Sales, Revenue and Gross Margin (2017-2022) 6.10.4 IBSA Institut Biochimque SA Non-opioid Pain Patches Product Portfolio 6.10.5 IBSA Institut Biochimque SA Recent Developments/Updates 6.11 Acorda Therapeutics 6.11.1 Acorda Therapeutics Corporation Information 6.11.2 Acorda Therapeutics Non-opioid Pain Patches Description and Business Overview 6.11.3 Acorda Therapeutics Non-opioid Pain Patches Sales, Revenue and Gross Margin (2017-2022) 6.11.4 Acorda Therapeutics Non-opioid Pain Patches Product Portfolio 6.11.5 Acorda Therapeutics Recent Developments/Updates 6.12 Allergan PLC 6.12.1 Allergan PLC Corporation Information 6.12.2 Allergan PLC Non-opioid Pain Patches Description and Business Overview 6.12.3 Allergan PLC Non-opioid Pain Patches Sales, Revenue and Gross Margin (2017-2022) 6.12.4 Allergan PLC Non-opioid Pain Patches Product Portfolio 6.12.5 Allergan PLC Recent Developments/Updates 6.13 Endo International 6.13.1 Endo International Corporation Information 6.13.2 Endo International Non-opioid Pain Patches Description and Business Overview 6.13.3 Endo International Non-opioid Pain Patches Sales, Revenue and Gross Margin (2017-2022) 6.13.4 Endo International Non-opioid Pain Patches Product Portfolio 6.13.5 Endo International Recent Developments/Updates 7 Non-opioid Pain Patches Manufacturing Cost Analysis 7.1 Non-opioid Pain Patches Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Non-opioid Pain Patches 7.4 Non-opioid Pain Patches Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Non-opioid Pain Patches Distributors List 8.3 Non-opioid Pain Patches Customers 9 Non-opioid Pain Patches Market Dynamics 9.1 Non-opioid Pain Patches Industry Trends 9.2 Non-opioid Pain Patches Market Drivers 9.3 Non-opioid Pain Patches Market Challenges 9.4 Non-opioid Pain Patches Market Restraints 10 Global Market Forecast 10.1 Non-opioid Pain Patches Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Non-opioid Pain Patches by Type (2023-2028) 10.1.2 Global Forecasted Revenue of Non-opioid Pain Patches by Type (2023-2028) 10.2 Non-opioid Pain Patches Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Non-opioid Pain Patches by Application (2023-2028) 10.2.2 Global Forecasted Revenue of Non-opioid Pain Patches by Application (2023-2028) 10.3 Non-opioid Pain Patches Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Non-opioid Pain Patches by Region (2023-2028) 10.3.2 Global Forecasted Revenue of Non-opioid Pain Patches by Region (2023-2028) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer
List of Tables Table 1. Global Non-opioid Pain Patches Sales Growth Rate Comparison by Type (2022-2028) & (K Pcs) & (US$ Million) Table 2. Global Non-opioid Pain Patches Sales Growth Rate Comparison by Application (2022-2028) & (K Pcs) & (US$ Million) Table 3. Global Non-opioid Pain Patches Market Size by Region (US$ Million) (2017 VS 2021 VS 2028) Table 4. Global Non-opioid Pain Patches Market Competitive Situation by Manufacturers in 2021 Table 5. Global Non-opioid Pain Patches Sales (K Pcs) of Key Manufacturers (2017-2022) Table 6. Global Non-opioid Pain Patches Sales Market Share by Manufacturers (2017-2022) Table 7. Global Non-opioid Pain Patches Revenue (US$ Million) by Manufacturers (2017-2022) Table 8. Global Non-opioid Pain Patches Revenue Share by Manufacturers (2017-2022) Table 9. Global Market Non-opioid Pain Patches Average Price (USD/Pcs) of Key Manufacturers (2017-2022) Table 10. Manufacturers Non-opioid Pain Patches Manufacturing Sites and Area Served Table 11. Manufacturers Non-opioid Pain Patches Product Type Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Non-opioid Pain Patches by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Non-opioid Pain Patches as of 2021) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Global Non-opioid Pain Patches Sales by Region (2017-2022) & (K Pcs) Table 16. Global Non-opioid Pain Patches Sales Market Share by Region (2017-2022) Table 17. Global Non-opioid Pain Patches Revenue by Region (2017-2022) & (US$ Million) Table 18. Global Non-opioid Pain Patches Revenue Market Share by Region (2017-2022) Table 19. North America Non-opioid Pain Patches Sales by Country (2017-2022) & (K Pcs) Table 20. North America Non-opioid Pain Patches Sales Market Share by Country (2017-2022) Table 21. North America Non-opioid Pain Patches Revenue by Country (2017-2022) & (US$ Million) Table 22. North America Non-opioid Pain Patches Revenue Market Share by Country (2017-2022) Table 23. Europe Non-opioid Pain Patches Sales by Country (2017-2022) & (K Pcs) Table 24. Europe Non-opioid Pain Patches Sales Market Share by Country (2017-2022) Table 25. Europe Non-opioid Pain Patches Revenue by Country (2017-2022) & (US$ Million) Table 26. Europe Non-opioid Pain Patches Revenue Market Share by Country (2017-2022) Table 27. Asia Pacific Non-opioid Pain Patches Sales by Region (2017-2022) & (K Pcs) Table 28. Asia Pacific Non-opioid Pain Patches Sales Market Share by Region (2017-2022) Table 29. Asia Pacific Non-opioid Pain Patches Revenue by Region (2017-2022) & (US$ Million) Table 30. Asia Pacific Non-opioid Pain Patches Revenue Market Share by Region (2017-2022) Table 31. Latin America Non-opioid Pain Patches Sales by Country (2017-2022) & (K Pcs) Table 32. Latin America Non-opioid Pain Patches Sales Market Share by Country (2017-2022) Table 33. Latin America Non-opioid Pain Patches Revenue by Country (2017-2022) & (US$ Million) Table 34. Latin America Non-opioid Pain Patches Revenue Market Share by Country (2017-2022) Table 35. Middle East and Africa Non-opioid Pain Patches Sales by Country (2017-2022) & (K Pcs) Table 36. Middle East and Africa Non-opioid Pain Patches Sales Market Share by Country (2017-2022) Table 37. Middle East and Africa Non-opioid Pain Patches Revenue by Country (2017-2022) & (US$ Million) Table 38. Middle East and Africa Non-opioid Pain Patches Revenue Market Share by Country (2017-2022) Table 39. Global Non-opioid Pain Patches Sales by Type (2017-2022) & (K Pcs) Table 40. Global Non-opioid Pain Patches Sales Market Share by Type (2017-2022) Table 41. Global Non-opioid Pain Patches Revenue by Type (2017-2022) & (US$ Million) Table 42. Global Non-opioid Pain Patches Revenue Share by Type (2017-2022) Table 43. Global Non-opioid Pain Patches Price by Type (2017-2022) & (USD/Pcs) Table 44. Global Non-opioid Pain Patches Sales (K Pcs) by Application (2017-2022) Table 45. Global Non-opioid Pain Patches Sales Market Share by Application (2017-2022) Table 46. Global Non-opioid Pain Patches Revenue by Application (2017-2022) & (US$ Million) Table 47. Global Non-opioid Pain Patches Revenue Share by Application (2017-2022) Table 48. Global Non-opioid Pain Patches Price by Application (2017-2022) & (USD/Pcs) Table 49. Pfizer Corporation Information Table 50. Pfizer Description and Business Overview Table 51. Pfizer Non-opioid Pain Patches Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022) Table 52. Pfizer Non-opioid Pain Patches Product Table 53. Pfizer Recent Developments/Updates Table 54. GlaxoSmithKline Corporation Information Table 55. GlaxoSmithKline Description and Business Overview Table 56. GlaxoSmithKline Non-opioid Pain Patches Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022) Table 57. GlaxoSmithKline Non-opioid Pain Patches Product Table 58. GlaxoSmithKline Recent Developments/Updates Table 59. Johnson & Johnson Corporation Information Table 60. Johnson & Johnson Description and Business Overview Table 61. Johnson & Johnson Non-opioid Pain Patches Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022) Table 62. Johnson & Johnson Non-opioid Pain Patches Product Table 63. Johnson & Johnson Recent Developments/Updates Table 64. Novartis AG Corporation Information Table 65. Novartis AG Description and Business Overview Table 66. Novartis AG Non-opioid Pain Patches Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022) Table 67. Novartis AG Non-opioid Pain Patches Product Table 68. Novartis AG Recent Developments/Updates Table 69. Mylan N.V. Corporation Information Table 70. Mylan N.V. Description and Business Overview Table 71. Mylan N.V. Non-opioid Pain Patches Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022) Table 72. Mylan N.V. Non-opioid Pain Patches Product Table 73. Mylan N.V. Recent Developments/Updates Table 74. Teva Pharmaceutical Industries Corporation Information Table 75. Teva Pharmaceutical Industries Description and Business Overview Table 76. Teva Pharmaceutical Industries Non-opioid Pain Patches Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022) Table 77. Teva Pharmaceutical Industries Non-opioid Pain Patches Product Table 78. Teva Pharmaceutical Industries Recent Developments/Updates Table 79. Hisamitsu Pharmaceutical Corporation Information Table 80. Hisamitsu Pharmaceutical Description and Business Overview Table 81. Hisamitsu Pharmaceutical Non-opioid Pain Patches Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022) Table 82. Hisamitsu Pharmaceutical Non-opioid Pain Patches Product Table 83. Hisamitsu Pharmaceutical Recent Developments/Updates Table 84. TEH SENG Pharmaceutical Corporation Information Table 85. TEH SENG Pharmaceutical Description and Business Overview Table 86. TEH SENG Pharmaceutical Non-opioid Pain Patches Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022) Table 87. TEH SENG Pharmaceutical Non-opioid Pain Patches Product Table 88. TEH SENG Pharmaceutical Recent Developments/Updates Table 89. Teikoku Seiyaku Corporation Information Table 90. Teikoku Seiyaku Description and Business Overview Table 91. Teikoku Seiyaku Non-opioid Pain Patches Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022) Table 92. Teikoku Seiyaku Non-opioid Pain Patches Product Table 93. Teikoku Seiyaku Recent Developments/Updates Table 94. IBSA Institut Biochimque SA Corporation Information Table 95. IBSA Institut Biochimque SA Description and Business Overview Table 96. IBSA Institut Biochimque SA Non-opioid Pain Patches Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022) Table 97. IBSA Institut Biochimque SA Non-opioid Pain Patches Product Table 98. IBSA Institut Biochimque SA Recent Developments/Updates Table 99. Acorda Therapeutics Corporation Information Table 100. Acorda Therapeutics Description and Business Overview Table 101. Acorda Therapeutics Non-opioid Pain Patches Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022) Table 102. Acorda Therapeutics Non-opioid Pain Patches Product Table 103. Acorda Therapeutics Recent Developments/Updates Table 104. Allergan PLC Corporation Information Table 105. Allergan PLC Description and Business Overview Table 106. Allergan PLC Non-opioid Pain Patches Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022) Table 107. Allergan PLC Non-opioid Pain Patches Product Table 108. Allergan PLC Recent Developments/Updates Table 109. Endo International Corporation Information Table 110. Endo International Description and Business Overview Table 111. Endo International Non-opioid Pain Patches Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022) Table 112. Endo International Non-opioid Pain Patches Product Table 113. Endo International Recent Developments/Updates Table 114. Production Base and Market Concentration Rate of Raw Material Table 115. Key Suppliers of Raw Materials Table 116. Non-opioid Pain Patches Distributors List Table 117. Non-opioid Pain Patches Customers List Table 118. Non-opioid Pain Patches Market Trends Table 119. Non-opioid Pain Patches Market Drivers Table 120. Non-opioid Pain Patches Market Challenges Table 121. Non-opioid Pain Patches Market Restraints Table 122. Global Non-opioid Pain Patches Sales Forecast by Type (2023-2028) & (K Pcs) Table 123. Global Non-opioid Pain Patches Sales Market Share Forecast by Type (2023-2028) Table 124. Global Non-opioid Pain Patches Revenue Forecast by Type (2023-2028) & (US$ Million) Table 125. Global Non-opioid Pain Patches Revenue Market Share Forecast by Type (2023-2028) Table 126. Global Non-opioid Pain Patches Sales Forecast by Application (2023-2028) & (K Pcs) Table 127. Global Non-opioid Pain Patches Sales Market Share Forecast by Application (2023-2028) Table 128. Global Non-opioid Pain Patches Revenue Forecast by Application (2023-2028) & (US$ Million) Table 129. Global Non-opioid Pain Patches Revenue Market Share Forecast by Application (2023-2028) Table 130. Global Non-opioid Pain Patches Sales Forecast by Region (2023-2028) & (K Pcs) Table 131. Global Non-opioid Pain Patches Sales Market Share Forecast by Region (2023-2028) Table 132. Global Non-opioid Pain Patches Revenue Forecast by Region (2023-2028) & (US$ Million) Table 133. Global Non-opioid Pain Patches Revenue Market Share Forecast by Region (2023-2028) Table 134. Research Programs/Design for This Report Table 135. Key Data Information from Secondary Sources Table 136. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of Non-opioid Pain Patches Figure 2. Global Non-opioid Pain Patches Market Share by Type in 2021 & 2028 Figure 3. Lidocaine Patch Product Picture Figure 4. Diclofenac Patch Product Picture Figure 5. Methyl Salicylate Patch Product Picture Figure 6. Capsaicin Patch Product Picture Figure 7. Ketoprofen Patch Product Picture Figure 8. Others Product Picture Figure 9. Global Non-opioid Pain Patches Market Share by Application in 2021 & 2028 Figure 10. Hospital Pharmacies Figure 11. Independent Pharmacies & Drug Stores Figure 12. Online Pharmacies Figure 13. Global Non-opioid Pain Patches Revenue, (US$ Million), 2017 VS 2021 VS 2028 Figure 14. Global Non-opioid Pain Patches Market Size (2017-2028) & (US$ Million) Figure 15. Global Non-opioid Pain Patches Sales (2017-2028) & (K Pcs) Figure 16. Non-opioid Pain Patches Sales Share by Manufacturers in 2021 Figure 17. Global Non-opioid Pain Patches Revenue Share by Manufacturers in 2021 Figure 18. The Global 5 and 10 Largest Non-opioid Pain Patches Players: Market Share by Revenue in 2021 Figure 19. Non-opioid Pain Patches Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021 Figure 20. Global Non-opioid Pain Patches Sales Market Share by Region (2017-2022) Figure 21. Global Non-opioid Pain Patches Sales Market Share by Region in 2021 Figure 22. Global Non-opioid Pain Patches Revenue Market Share by Region (2017-2022) Figure 23. Global Non-opioid Pain Patches Revenue Market Share by Region in 2021 Figure 24. U.S. Non-opioid Pain Patches Revenue Growth Rate (2017-2022) & (US$ Million) Figure 25. Canada Non-opioid Pain Patches Revenue Growth Rate (2017-2022) & (US$ Million) Figure 26. Germany Non-opioid Pain Patches Revenue Growth Rate (2017-2022) & (US$ Million) Figure 27. France Non-opioid Pain Patches Revenue Growth Rate (2017-2022) & (US$ Million) Figure 28. U.K. Non-opioid Pain Patches Revenue Growth Rate (2017-2022) & (US$ Million) Figure 29. Italy Non-opioid Pain Patches Revenue Growth Rate (2017-2022) & (US$ Million) Figure 30. Russia Non-opioid Pain Patches Revenue Growth Rate (2017-2022) & (US$ Million) Figure 31. China Non-opioid Pain Patches Revenue Growth Rate (2017-2022) & (US$ Million) Figure 32. Japan Non-opioid Pain Patches Revenue Growth Rate (2017-2022) & (US$ Million) Figure 33. South Korea Non-opioid Pain Patches Revenue Growth Rate (2017-2022) & (US$ Million) Figure 34. India Non-opioid Pain Patches Revenue Growth Rate (2017-2022) & (US$ Million) Figure 35. Australia Non-opioid Pain Patches Revenue Growth Rate (2017-2022) & (US$ Million) Figure 36. Taiwan Non-opioid Pain Patches Revenue Growth Rate (2017-2022) & (US$ Million) Figure 37. Indonesia Non-opioid Pain Patches Revenue Growth Rate (2017-2022) & (US$ Million) Figure 38. Thailand Non-opioid Pain Patches Revenue Growth Rate (2017-2022) & (US$ Million) Figure 39. Malaysia Non-opioid Pain Patches Revenue Growth Rate (2017-2022) & (US$ Million) Figure 40. Philippines Non-opioid Pain Patches Revenue Growth Rate (2017-2022) & (US$ Million) Figure 41. Vietnam Non-opioid Pain Patches Revenue Growth Rate (2017-2022) & (US$ Million) Figure 42. Mexico Non-opioid Pain Patches Revenue Growth Rate (2017-2022) & (US$ Million) Figure 43. Brazil Non-opioid Pain Patches Revenue Growth Rate (2017-2022) & (US$ Million) Figure 44. Argentina Non-opioid Pain Patches Revenue Growth Rate (2017-2022) & (US$ Million) Figure 45. Turkey Non-opioid Pain Patches Revenue Growth Rate (2017-2022) & (US$ Million) Figure 46. Saudi Arabia Non-opioid Pain Patches Revenue Growth Rate (2017-2022) & (US$ Million) Figure 47. U.A.E Non-opioid Pain Patches Revenue Growth Rate (2017-2022) & (US$ Million) Figure 48. Sales Market Share of Non-opioid Pain Patches by Type (2017-2022) Figure 49. Manufacturing Cost Structure of Non-opioid Pain Patches Figure 50. Manufacturing Process Analysis of Non-opioid Pain Patches Figure 51. Non-opioid Pain Patches Industrial Chain Analysis Figure 52. Channels of Distribution Figure 53. Distributors Profiles Figure 54. Bottom-up and Top-down Approaches for This Report Figure 55. Data Triangulation Figure 56. Key Executives Interviewed
Pfizer GlaxoSmithKline Johnson & Johnson Novartis AG Mylan N.V. Teva Pharmaceutical Industries Hisamitsu Pharmaceutical TEH SENG Pharmaceutical Teikoku Seiyaku IBSA Institut Biochimque SA Acorda Therapeutics Allergan PLC Endo International
Advanced Energy Storage market is segmented by players, region (country), by Type and by Applicat ... Read More
The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More
The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More
The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More